The Proxima spatial analysis software solution integrates image acquisition to data analysis in the secure cloud for rapid access by any user
cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus
Join Waters on Wednesday, October 7, for a panel discussion and insights from the USP and MHRA
The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors
Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed
AstraZeneca anticipates entering clinical development in 2021
The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus
The partnership aims to co-market exosome technology as well as the joint development of new exosome based products
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs
Join us on Thursday, September 24, to learn more about new updates of the NanoDrop One platform
Quick start electronic lab notebook helps start-ups capture experimental data, collaborate with ease and secure their IP from day one
New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions
FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers
Learn how small data systems can enhance overall reliability, traceability, and reproducibility in the lab in this on-demand webinar
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
